Superficial Radiotherapy (SRT) is a safe and effective treatment option for many patients experiencing non-melanoma skin cancers, like basal cell carcinoma and squamous cell carcinoma.  Patients often find its less invasive nature an appealing alternative to surgery for sensitive or cosmetically forward areas like the face and neck.  The innovation and precision available with Superficial Radiotherapy Treatments provide a safe, effective, and patient-centric treatment option for non-melanoma skin cancers.

One major difference between SRT and traditional radiation therapy is the depth of penetration. SRT is designed to precisely target cancerous cells in a specific area on the skin while sparing deeper and surrounding healthy tissue. This benefits patients with other health concerns who want or need a more gentle approach to treating their skin cancer. SRT also has minimal downtime, allowing for a faster recovery than traditional treatment methods.

Another benefit of SRT for skin cancer treatment is its non-invasive nature.  This means the treatment is administered without any numbing injections, incisions, or bleeding and results in healing without surgical scarring or stitches.  Patients appreciate having an option like SRT for their skin cancer treatment, especially when age or associated medical conditions make them high-risk candidates for surgery.

Sensus Healthcare technologies offer safe and effective SRT for non-melanoma skin cancer treatment. Their innovative solutions include the SRT-100™, SRT-100™+, and the SRT Vision state-of-the-art devices that bring cutting-edge therapy directly into local dermatology clinics. Patients deserve comfortable, safe, and effective treatment options for skin cancer, and Sensus is a committed leader in the healthcare industry.

Visit our website to learn more about treatment with Superficial Radiotherapy and ask your doctor if it’s an option for you.